
Chugai Pharmaceutical
CHGCY | OTC
$22.94
+$0.39 (+1.73%)
At close: Nov 16, 2026, 3:59 PM ET
$22.99
+$0.05 (+0.22%)
After-hours:
Nov 16, 2026, 3:57 PM ET
+1.73%
(1D)No price chart data available for 1D timeframe.
Rating
68.8
+0.9 ptsFundamentals Excellent
Market Sentiment Neutral
Moat Wide
Sector Rank #67/1021 (Top 7%)
Why Price Moved
20 days ago
+1.51%
Shares are trading higher following the company's ...
Key Statistics
Market Data
Market Cap $75.5B
1D Range
22.94 23.17
52W Range
19.08 33.61
Valuation (TTM)
PE 23.58
PB 5.69
EV/EBITDA 15.63
Valuation (NTM)
Forward PE 23.11
Forward PEG 1.40
Price Target $0.00
Cash Flow
FCF Yield 3.0%
SBC Adj. FCF Yield 3.0%
SBC Impact N/A
Margins
Gross Margin 71.5%
Operating Margin 46.5%
FCF Margin 25.7%
Growth (CAGR)
Revenue 3Y | 5Y 3.5% |
9.8%
Dil EPS 3Y | 5Y 14.4% |
14.4%
FCF 3Y | 5Y 24.0% |
15.0%
Returns
ROA 21.2%
ROE 25.0%
ROIC 22.2%
Financial Health
Net Cash
¥869B ($5.52B)
Current Ratio 6.39
Interest Coverage 720.02
Dividends
Div Yield 5.45%
Payout Ratio 0.4%
FCF Payout Ratio 96.5%
Loading financial charts...
Profile
Chugai Pharmaceutical Co., Ltd. engages in the research, development, manufacturing, sale, importation, and exportation of pharmaceuticals. Its operations are carried out through the Domestic and Over...
Sector Healthcare
Industry Drug Manufacturers - General
Employees 7,872
IPO Date Aug 3, 2012
Website www.chugai-pharm.co.jp
Fiscal Year January - December
Latest News
21 days ago · seekingalpha.com
Chugai Pharmaceutical Co., Ltd. (CHGCY) Q3 2026 Earnings Call TranscriptChugai Pharmaceutical Co., Ltd. (CHGCY) Q3 2026 Earnings Call Transcript
4 months ago · seekingalpha.com
Chugai Pharmaceutical Co., Ltd. (CHGCY) Q2 2026 Earnings Call TranscriptChugai Pharmaceutical Co., Ltd. (CHGCY) Q2 2026 Earnings Call Transcript
Add to Watchlist
Select watchlists to add or remove CHGCY